{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:04:05Z","timestamp":1790629445165,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["2024-146"],"award-info":[{"award-number":["2024-146"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["MIS F. 4005 . 24"],"award-info":[{"award-number":["MIS F. 4005 . 24"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["CDR J. 0018 . 25"],"award-info":[{"award-number":["CDR J. 0018 . 25"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005627","name":"Universit\u00e9 de Li\u00e8ge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006282","name":"Koning Boudewijnstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006673","name":"Fonds L\u00e9on Fredericq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biochi.2026.09.012","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:05:17Z","timestamp":1790147117000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sphingolipids as central regulators of therapy resistance and immunity in lung cancer"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8211-672X","authenticated-orcid":false,"given":"Morgane","family":"Paque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4939-0473","authenticated-orcid":false,"given":"Anisa","family":"Aliju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-8726","authenticated-orcid":false,"given":"Arnaud","family":"Blomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2026.09.012_bib1","first-page":"368","article-title":"Metabolic reprogramming and cancer progression","volume":"2020","author":"Faubert","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.biochi.2026.09.012_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71317","article-title":"Metabolic reprogramming in lung cancer: Hallmarks, mechanisms, and targeted strategies to overcome immune resistance","volume":"14","author":"Chen","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.biochi.2026.09.012_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41571-025-01021-1","article-title":"Tumour and microenvironment crosstalk in NSCLC progression and response to therapy","volume":"22","author":"Rahal","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biochi.2026.09.012_bib4","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jtho.2021.04.020","article-title":"Visceral obesity promotes lung cancer Progression\u2014Toward resolution of the obesity paradox in lung cancer","volume":"16","author":"Barbi","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.biochi.2026.09.012_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abk2756","article-title":"Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis","volume":"14","author":"Wang","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biochi.2026.09.012_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1548655","article-title":"Investigation of sphingolipid-related genes in lung adenocarcinoma","volume":"12","author":"Mao","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biochi.2026.09.012_bib7","article-title":"Anti-ceramide antibody and sphingosine-1-phosphate as potential biomarkers of unresectable non-small cell lung cancer","volume":"30","author":"B\u0171di","year":"2024","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.biochi.2026.09.012_bib8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/1055-9965.EPI-12-1424","article-title":"Plasma sphingolipids and lung cancer: a population-based, nested case-control study","volume":"22","author":"Alberg","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.biochi.2026.09.012_bib9","article-title":"Bioactive sphingolipids as emerging targets for signal transduction in cancer development","volume":"1879","author":"Jia","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.biochi.2026.09.012_bib10","first-page":"88","article-title":"Sphingolipid metabolism dysregulation: a cause for lung cancer development, progression, and resistance to therapies","volume":"3","author":"Mao","year":"2025"},{"key":"10.1016\/j.biochi.2026.09.012_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biochi.2026.09.012_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101438","article-title":"Serine metabolism in the central nervous system: advances and challenges on a conditionally essential amino acid","volume":"107","author":"Kustrimovic","year":"2026","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.biochi.2026.09.012_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15071994","article-title":"Ceramide synthase 1 inhibits brain metastasis of non-small cell lung cancer by interacting with USP14 and downregulating the PI3K\/AKT\/mTOR signaling pathway","volume":"15","author":"Xu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biochi.2026.09.012_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106850","article-title":"CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer","volume":"194","author":"Wang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biochi.2026.09.012_bib15","doi-asserted-by":"crossref","first-page":"11949","DOI":"10.1111\/jcmm.15817","article-title":"CERS6 required for cell migration and metastasis in lung cancer","volume":"24","author":"Suzuki","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biochi.2026.09.012_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9099612","article-title":"Sphingolipid metabolism and signaling in lung cancer: a potential therapeutic target","volume":"2022","author":"Lin","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.biochi.2026.09.012_bib17","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1158\/1078-0432.CCR-10-0720","article-title":"Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K\/Akt\/NF-\u03baB pathway in human non-small cell lung cancer","volume":"17","author":"Song","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biochi.2026.09.012_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.febslet.2007.01.041","article-title":"Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells","volume":"581","author":"Mitra","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biochi.2026.09.012_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010227","article-title":"Implication of ceramide Kinase\/C1P in cancer development and progression","volume":"14","author":"Camacho","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biochi.2026.09.012_bib20","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1158\/0008-5472.CAN-16-3313","article-title":"Enhanced acid sphingomyelinase activity drives immune evasion and tumor growth in non\u2013small cell lung carcinoma","volume":"77","author":"Kachler","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.biochi.2026.09.012_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0340437","article-title":"Sphingolipid metabolism-related genes B4GALNT1 and CERS4 as prognostic biomarkers in lung adenocarcinoma","volume":"21","author":"Jeon","year":"2026","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2026.09.012_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103301","article-title":"A circular network of coregulated sphingolipids dictates lung cancer growth and progression","volume":"66","author":"Meng","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biochi.2026.09.012_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70435","article-title":"Machine learning unveils Sphingolipid metabolism\u2019s role in tumour microenvironment and immunotherapy in lung cancer","volume":"29","author":"Xu","year":"2025","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biochi.2026.09.012_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07306-1","article-title":"Sphingomyelin(d35:1) as a novel predictor for lung adenocarcinoma recurrence after a radical surgery: a case-control study","volume":"20","author":"Takanashi","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biochi.2026.09.012_bib25","doi-asserted-by":"crossref","first-page":"25435","DOI":"10.1021\/acs.analchem.5c02746","article-title":"Lipidomic profiling of metastatic lung cancer-derived exosomes unveiling ceramides as potential biomarkers by supramolecular probe enrichment and mass spectrometry analysis","volume":"97","author":"Zhao","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.biochi.2026.09.012_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.807636","article-title":"The role of sphingolipids metabolism in cancer drug resistance","volume":"11","author":"Bataller","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biochi.2026.09.012_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083716","article-title":"Drug resistance: the role of sphingolipid metabolism","volume":"26","author":"Zhakupova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2026.09.012_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4714-x","article-title":"LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain","volume":"18","author":"Huang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biochi.2026.09.012_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.186","article-title":"Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer","volume":"3","author":"Paul","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biochi.2026.09.012_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl7895","article-title":"Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models","volume":"15","author":"Su","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biochi.2026.09.012_bib31","series-title":"Glycosphingolipid GM2 Induces Invasiveness in irradiation-tolerant Lung Cancer Cells","author":"Ishihara","year":"2018"},{"key":"10.1016\/j.biochi.2026.09.012_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.33594\/000000726","article-title":"ASMase is essential for the immune response to partial-tumor radiation exposure","volume":"58","author":"Mathieu","year":"2024","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biochi.2026.09.012_bib33","article-title":"Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models","volume":"14","author":"La","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2026.09.012_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2016.05.102","article-title":"Inhibition of ceramide glucosylation sensitizes lung cancer cells to ABC294640, a first-in-class small molecule SphK2 inhibitor","volume":"476","author":"Guan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2026.09.012_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2016.00218","article-title":"Sphingosine-1 phosphate: a new modulator of immune plasticity in the tumor microenvironment","volume":"6","author":"Rodriguez","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biochi.2026.09.012_bib36","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/1759-7714.15283","article-title":"Single-cell RNA sequencing reveals aberrant sphingolipid metabolism in non-small cell lung cancer impacts tumor-associated macrophages and stimulates angiogenesis via macrophage inhibitory factor signaling","volume":"15","author":"Shen","year":"2024","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.biochi.2026.09.012_bib37","article-title":"Ceramide pathway regulators predict clinical prognostic risk and affect the tumor immune microenvironment in lung adenocarcinoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biochi.2026.09.012_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.70234","article-title":"Bioactive sphingolipids of Cordyceps sinensis modulate tumor immunity through the SphK1-Mediated Cer\/S1P axis","author":"Kuang","year":"2026","journal-title":"Phytother Res."},{"key":"10.1016\/j.biochi.2026.09.012_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316901","article-title":"Opaganib (ABC294640) induces immunogenic tumor cell death and enhances checkpoint antibody therapy","volume":"24","author":"Maines","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2026.09.012_bib40","series-title":"The Function of cancer-shed Gangliosides in Macrophage Phenotype: Involvement with Angiogenesis","author":"Chung","year":"2017"},{"key":"10.1016\/j.biochi.2026.09.012_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003897","article-title":"Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer","volume":"10","author":"Reppel","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biochi.2026.09.012_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.lungcan.2022.03.003","article-title":"Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer","volume":"166","author":"Edelman","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.biochi.2026.09.012_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262412029","article-title":"Overexpression of GM3 and ganglioside pattern remodeling in lung Adenocarcinoma brain metastases identified by ion Mobility Mass spectrometry","volume":"26","author":"Sarbu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2026.09.012_bib44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/14737140.2017.1364995","article-title":"Anti-GD2 immunotherapy for neuroblastoma","volume":"17","author":"Sait","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.biochi.2026.09.012_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-9-180","article-title":"Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer","volume":"9","author":"van Cruijsen","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biochi.2026.09.012_bib46","article-title":"Real-World effectiveness of racotumomab as maintenance therapy in advanced non-small cell lung cancer patients","volume":"13","author":"Alfonso","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.biochi.2026.09.012_bib47","article-title":"Ganglioside therapy in cancer molecular insights and therapeutic opportunities","volume":"16","author":"Banerjee","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.biochi.2026.09.012_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-42885-2","article-title":"Harnessing a bispecific \u03b1GD2 \u00d7 \u03b1CD3 protein engager to target GD2-overexpressing lung tumors","author":"Sawasdee","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2026.09.012_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162524","article-title":"S1P-Induced TNF-\u03b1 and IL-6 release from PBMCs exacerbates lung cancer-associated inflammation","volume":"11","author":"Terlizzi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biochi.2026.09.012_bib50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.33594\/000000361","article-title":"Sphingosine-1-phosphate contributes to TLR9-induced TNF-\u03b1 release in lung tumor cells","volume":"55","author":"Terlizzi","year":"2021","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biochi.2026.09.012_bib51","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cellsig.2004.12.005","article-title":"Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1\u03b2 and TNF-\u03b1 induced production of inflammatory mediators","volume":"17","author":"Billich","year":"2005","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biochi.2026.09.012_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098303","article-title":"Induction of inflammation disrupts the negative interplay between STING and S1P axis that is observed during physiological conditions in the lung","volume":"24","author":"Terlizzi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2026.09.012_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw5001","article-title":"In situ\u2013formed immunotherapeutic hydrogel containing sphingosine-1-phosphate for enhanced lung cancer immunotherapy","volume":"11","author":"Shen","year":"2025","journal-title":"Sci. Adv."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426002312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426002312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:28:05Z","timestamp":1790627285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908426002312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":53,"alternative-id":["S0300908426002312"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2026.09.012","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingolipids as central regulators of therapy resistance and immunity in lung cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2026.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}